Holm Jakob Præst, Hyldstrup Lars, Jensen Jens-Erik Beck
Department of Endocrinology, Copenhagen University Hospital Hvidovre, Kettegaards Allé 30, 2650, Hvidovre, Denmark.
Endocrine. 2016 Oct;54(1):241-255. doi: 10.1007/s12020-016-0987-5. Epub 2016 May 13.
The aim of this article was to identify prevalent osteoporosis risk factors, medications and comorbidities associated with bone mineral density (BMD). Furthermore to evaluate changes in risk factor profiles over 12 years. 6285 women consecutively referred to an osteoporosis specialist clinic were included. Information of potential risk factors was obtained by questionnaire and clinical examination. Additional information on medication use, comorbidities and fractures were obtained from national registries. An association (<0.05) between well-known risk factors negatively influencing bone health was established in a real-life setting. The prevalence of osteoporosis and proportion of patient's having comorbidity's associated with osteoporosis were increasing during the inclusion period (start 23.8 %, end 29.7 %). Increasing age (OR = 1.05), current smoking (OR = 1.18), estrogen deficiency (OR = 1.7), hyperthyroidism (OR = 1.5), previous major osteoporotic fracture (OR = 1.7), former osteoporosis treatment (OR = 3.5), higher BMI (OR = 0.87), use of calcium supplementation (OR = 1.2), high exercise level (OR = 0.7), and use of thiazide diuretics (OR = 0.7) were identified as predictors of osteoporosis by DXA. Rheumatoid arthritis (OR = 2.4) and chronic pulmonary disease (OR = 1.5) was associated with site-specific osteoporosis by DXA at the total hip. Current use of loop diuretics (OR = 1.7) and glucocorticoid use (OR = 1.04-1.06) were associated with both total hip and femoral neck T-score <-2.5. Our data confirms an independent negative association with BMD of many established risk factors, certain comorbidities, and medications. Exercise level, use of loop diuretics, and prevalent chronic pulmonary disease, risk factors not included in fracture risk calculators were associated with osteoporosis by DXA. Time trends indicate risk profile is dynamic, with increasing focus on secondary osteoporosis.
本文旨在确定与骨密度(BMD)相关的常见骨质疏松症风险因素、药物和合并症。此外,还评估了12年间风险因素概况的变化。研究纳入了连续转诊至骨质疏松症专科诊所的6285名女性。通过问卷调查和临床检查获取潜在风险因素的信息。从国家登记处获取有关药物使用、合并症和骨折的其他信息。在现实生活环境中确定了对骨骼健康有负面影响的知名风险因素之间的关联(<0.05)。在纳入期间,骨质疏松症的患病率以及患有与骨质疏松症相关合并症的患者比例在增加(开始时为23.8%,结束时为29.7%)。年龄增长(OR = 1.05)、当前吸烟(OR = 1.18)、雌激素缺乏(OR = 1.7)、甲状腺功能亢进(OR = 1.5)、既往严重骨质疏松性骨折(OR = 1.7)、既往骨质疏松症治疗(OR = 3.5)、较高的体重指数(OR = 0.87)、使用钙补充剂(OR = 1.2)、高运动水平(OR = 0.7)以及使用噻嗪类利尿剂(OR = 0.7)被双能X线吸收法(DXA)确定为骨质疏松症的预测因素。类风湿性关节炎(OR = 2.4)和慢性肺病(OR = 1.5)与全髋关节DXA检查显示的特定部位骨质疏松症相关。当前使用袢利尿剂(OR = 1.7)和使用糖皮质激素(OR = 1.04 - 1.06)与全髋关节和股骨颈T值<-2.5均相关。我们的数据证实了许多既定风险因素、某些合并症和药物与骨密度之间存在独立的负相关。运动水平、袢利尿剂的使用以及普遍存在的慢性肺病,这些骨折风险计算器中未包含的风险因素与DXA检查显示的骨质疏松症相关。时间趋势表明风险概况是动态的,对继发性骨质疏松症的关注日益增加。